|
WO2021026378A1
|
|
Indole compounds for the treatment of pain
|
|
WO2021026375A1
|
|
Fused bicyclic compounds for the treatment of pain
|
|
WO2021026380A1
|
|
Phenyltriazole compounds for the treatment of pain
|
|
WO2021026377A1
|
|
Lactam-containing compounds for the treatment of pain
|
|
WO2021016413A1
|
|
Synthesis of bicyclic inhibitors of histone deacetylase
|
|
AU2019301761A1
|
|
Bicyclic inhibitors of histone deacetylase
|
|
CA3106355A1
|
|
Inhibitors of histone deacetylase
|
|
AU2019216522A1
|
|
Compounds for the treatment of pain
|
|
AU2017291321A1
|
|
Compositions and methods for modulating IL-10 immunostimulatory and anti-inflammatory properties
|
|
US2016243112A1
|
|
Treatments for alzheimer's related diseases and disorders
|
|
AU2015364396A1
|
|
Single chain Fc fusion proteins
|
|
EP2874639A2
|
|
Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide
|
|
AU2012275181A1
|
|
Peripherally acting opioid compounds
|
|
WO2012138888A1
|
|
Process for the synthesis of quaternary amine compounds
|
|
WO2012112525A1
|
|
PERIPHERIALLY ACTING μ OPIOID ANTAGONISTS
|
|
WO2012088441A1
|
|
Multi- api loading prodrugs
|
|
US2011166194A1
|
|
Asenapine Prodrugs
|
|
WO2011084850A1
|
|
Prodrugs for the treatment of schizophrenia and bipolar disease
|
|
WO2011084849A1
|
|
Diaryldiazepine prodrugs for the treatment of neurological and psychological disorders
|
|
US2011123574A1
|
|
Inhalable sustained therapeutic formulations
|
